| 摘要 |
<p>The invention concerns a novel complex LSR (Lipolysis Stimulated Receptor) polypeptide receptor, characterised by its functional activities, the cloning of DNAc complementary to RNAs messengers coding for each of the subunits of the multimer complex, vectors and transformed cells, methods for diagnosing and selecting compounds useful as medicine for preventing and/or treating pathologies and/or pathogenic conditions such as obesity and anorexia, hyperlipemia, atherosclerosis, diabetes, hypertension, and more generally the various pathologies associated with anomalies of the cytokin metabolism.</p> |
